BAY11-7082 Targets RNF25 to Reverse TRIP4 Ubiquitination-dependent NF-κB Activation and Apoptosis Resistance in Renal Cell Carcinoma. Here, RNF25 is linked to hereditary clear cell renal cell carcinoma.